Phase I, Open-Label Study of the Safety, Tolerability, and Immunogenicity PEK Fusion Protein Vaccine

NCT01880411 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

15

Enrollment

INDUSTRY

Sponsor class

Conditions

Cervical Intraepithelial Neoplasia

Interventions

BIOLOGICAL: PEK Fusion Protein Vaccine

Sponsor

HealthBanks Biotech Co., Ltd.